Implantable Nerve Band Medical Device Allows Surgeons to Rejoin Injured Nerves Without Sutures – Surgical Techniques

Image: Nerve Tape will enable suture-free surgical repair after traumatic injuries (Photo courtesy of BioCircuit Technologies)

A new medical device that enables sutureless nerve repair following traumatic injuries will allow surgeons to operate faster and achieve precise and reliable joining of injured nerves, simplifying the surgical process and improving patient outcomes .

BioCircuit Technologies (Atlanta, GA, USA) and Smithfield BioScience (Smithfield, Va., USA) have developed Nerve Tape, an implantable device comprised of decellularized porcine intestinal submucosa (SIS) embedded with microscopic hooks for tissue fixation. It can be quickly and easily wrapped around both ends of a severed nerve to form a strong, reliable connection with distributed tension to promote regeneration. The devices will be prepared from fully traceable SIS tissue harvested from Smithfield’s US operations.

Along with establishing a commercial supply chain for Nerve Tape®, BioCircuit is also developing non-invasive bioelectronic devices capable of harnessing nerve and muscle activity to provide sensitive, high-resolution monitoring and selective loop stimulation. closed. Useful in the fields of bioelectronic medicine, neuromodulation, neuroprosthetics, and neuromuscular rehabilitation, this bioelectronic technology allows clinicians to diagnose health conditions earlier, accurately deliver therapies, and track outcomes over time. time.

“Our work with BioCircuit demonstrates our expanding portfolio and the value we create in a variety of markets through Smithfield’s vertically integrated supply chain and manufacturing expertise,” said Courtney Stanton, president of Smithfield BioScience. . “By harvesting porcine bioproducts for medical applications – like organs, mucous membranes and tissues – we have the ability to improve lives through the development of innovative pharmaceuticals and medical devices like this.”

“We look forward to working with Smithfield BioScience to bring this promising medical device solution to life,” said Michelle Jarrard, CEO of BioCircuit Technologies. “BioCircuit is committed to developing medical technologies, such as Nerve Tape, to repair, monitor and control peripheral nerves with precision and reliability. We are excited to leverage Smithfield’s exceptional level of product traceability and safety in our work to provide surgeons with powerful, practical clinical tools that enhance the treatment of injuries.”

Related links:

BioCircuit Technologies

Smithfield BioScience

Comments are closed.